{"brief_title": "Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)", "brief_summary": "The purpose of this randomized clinical trial is to determine if lowering homocysteine levels in renal transplant recipients with a multivitamin will reduce the occurrence of cardiovascular disease outcomes.", "detailed_description": "The hypothesis of the trial is as follows: Treatment with a high dose combination of folic acid, vitamin B6, and vitamin B12 will reduce the rate of pooled arteriosclerotic cardiovascular disease outcomes (i.e., pooled occurrence of non-fatal and fatal arteriosclerotic outcomes, including coronary heart, cerebrovascular, and peripheral vascular disease events) relative to treatment with an identical multivitamin containing no folic acid, and Estimated Average Requirement amounts of vitamin B6, vitamin B12, among chronic, stable renal transplant recipients", "condition": "Death", "intervention_type": "Device", "intervention_name": "Low Dose Multivitamin", "description": "Vitamin B6 (Pyridoxine HCl): 1.4 mg Folic acid: 0.0 mg Vitamin B12: 2.0 mcg Vitamin B1 (Thiamine HNO3): 1.5 mg Vitamin B2 (Riboflavin): 1.5 mg Vitamin C (Ascorbic Acid): 60 mg d-Biotin: 300 mcg Niacinamide: 20 mg Pantothenic Acid Calcium Pantothenate): 10 mg", "arm_group_label": "Low Dose Multivitamin", "other_name": "multivitamin", "criteria": "Inclusion Criteria: - 35 - 75 years old - Had kidney transplant at least 6 months - Calculated Creatinine Clearance must be 25mL/min or greater - Must be willing to stop supplements (B6, B12, folic acid) for 4-6 weeks prior to visit Exclusion Criteria: - If pregnant or lactating - If of child bearing potential and not on birth control - If any of the following will limit life expectancy to less than 2 yrs: - Cancer - CHF (end stage) - Liver disease (end stage) - Severe pulmonary disease - Progressive HIV - Any other chronic wasting illness - If patient had MI, stroke, lower extremity amputation above ankle or percutaneous revascularization procedure (coronary, cerebrovascular, lower extremity) in past 2months - If patient had CABG or AAA in past 5 months - If patient has conditions that prevent reliable study participation e.g., depression, alcohol or drug abuse, other CVD studies - If patient has had multi-organ transplant, except kidney/pancreas", "gender": "All", "minimum_age": "35 Years", "maximum_age": "75 Years", "healthy_volunteers": "No", "id": "NCT00064753.xml"}